Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Feasibility Study of GlaxoSmithKline Biologicals’ GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Feasibility Study of the Reia Vaginal Pessary: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Study of the Reia Vaginal Pessary: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04508335).
- Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL): Complete Statistical AnalysisIndependent statistical analysis of Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL): primary endpoint results, effect estimate with confidence interval, sample-size…
- Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Feasibility Trial Using an Inpatient Insulin Dosing Calculator: Complete Statistical AnalysisIndependent statistical analysis of Feasibility Trial Using an Inpatient Insulin Dosing Calculator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06206525).
- Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD: Complete Statistical AnalysisIndependent statistical analysis of Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD: primary endpoint results, effect estimate with…
- FEASTIndependent statistical analysis of Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- FEAStIndependent statistical analysis of Fostering Eating After Stroke With Transcranial Direct Current Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01919112).
- FEATUREIndependent statistical analysis of A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy: primary endpoint results, effect estimate with confidence…
- Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn’s Colitis: Complete Statistical AnalysisIndependent statistical analysis of Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Fecal Microbiota Transplantation (FMT) for MDRO UTI: Complete Statistical AnalysisIndependent statistical analysis of Fecal Microbiota Transplantation (FMT) for MDRO UTI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03367910).
- Fenofibrate Treatment in SCI: Complete Statistical AnalysisIndependent statistical analysis of Fenofibrate Treatment in SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02455336).
- Fentanyl for Breakthrough Pain in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Fentanyl for Breakthrough Pain in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01812759).
- Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea: Complete Statistical AnalysisIndependent statistical analysis of Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01832402).
- FermCarbIndependent statistical analysis of Effect of Fermentable Carbohydrate on Glucose Homeostasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01841073).
- Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion: Complete Statistical AnalysisIndependent statistical analysis of Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Fetal Tracheal Balloon Study in Diaphragmatic Hernia: Complete Statistical AnalysisIndependent statistical analysis of Fetal Tracheal Balloon Study in Diaphragmatic Hernia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966823).
- Fetoscopic NEOX Cord 1K® Spina Bifida Repair: Complete Statistical AnalysisIndependent statistical analysis of Fetoscopic NEOX Cord 1K® Spina Bifida Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243889).
- Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense: Complete Statistical AnalysisIndependent statistical analysis of Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03974178).
- FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03212170).
- FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00999037).
- Fibrin Glue in Inguinal Lymphadenectomy: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Glue in Inguinal Lymphadenectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04666051).
- Fibrin Melanoma Axillary Node Study in Patients With Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Melanoma Axillary Node Study in Patients With Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00504582).
- Fibrin Sealant Vascular Surgery Study: Complete Statistical AnalysisIndependent statistical analysis of Fibrin Sealant Vascular Surgery Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00576420).
- FIDELIO-DKDIndependent statistical analysis of Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A: Complete Statistical AnalysisIndependent statistical analysis of Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FIGARO UC 303Independent statistical analysis of An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- FIGHT-210Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration: primary endpoint results, effect…
- Figure 8Independent statistical analysis of Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea – A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FINANCE-DMIndependent statistical analysis of Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04203173).
- Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02210832).
- Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program: Complete Statistical AnalysisIndependent statistical analysis of Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- finCATIndependent statistical analysis of A Study of Cognitive Adaptation Training in Inpatient Forensic Environments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04294719).
- FINCH 1Independent statistical analysis of Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate: primary endpoint results, effect estimate with confidence…
- FireballIndependent statistical analysis of A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- FIREFLEYEIndependent statistical analysis of Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FIRSTIndependent statistical analysis of Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma: primary endpoint results, effect estimate with…
- First – In – Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism: Complete Statistical AnalysisIndependent statistical analysis of First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism: primary endpoint results, effect…
- First HeroesIndependent statistical analysis of First Heroes: Engaging Fathers in the First 1000 Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04477577).
- First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone: Complete Statistical AnalysisIndependent statistical analysis of First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone: primary endpoint results, effect estimate with confidence interval,…
- First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent: Complete Statistical AnalysisIndependent statistical analysis of First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study: Complete Statistical AnalysisIndependent statistical analysis of First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study: primary endpoint…
- First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Complete Statistical AnalysisIndependent statistical analysis of First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High…
- First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.: Complete Statistical AnalysisIndependent statistical analysis of First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.: primary endpoint results, effect estimate with…
- First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221: Complete Statistical AnalysisIndependent statistical analysis of First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…